Pretreatment Neutrophil-to-Lymphocyte Ratio (NLR) May Predict the Outcomes of Advanced Non-small-cell Lung Cancer (NSCLC) Patients Treated With Immune Checkpoint Inhibitors (ICIs)

Background: Recent studies have demonstrated the predictive value of pretreatment neutrophil-to-lymphocyte ratio (NLR) in advanced cancers; however, the role of NLR in patients with advanced non-small-cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICIs) remained to be explored....

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ye, Zhang, Zhibo, Hu, Yi, Yan, Xiang, Song, Qi, Wang, Guoqiang, Chen, Runzhe, Jiao, Shunchang, Wang, Jinliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7324627/
https://www.ncbi.nlm.nih.gov/pubmed/32656072
http://dx.doi.org/10.3389/fonc.2020.00654

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7324627/
https://www.ncbi.nlm.nih.gov/pubmed/32656072
http://dx.doi.org/10.3389/fonc.2020.00654

Ejemplares similares